Evidence map›Paper›PMID 41806854›Full record

Trial reportAmerican journal of perinatology2026

Association between Neonatal Hypoglycemia and 30-Day Breastfeeding Outcomes among Gravidas with Type 2 Diabetes.

Daniella Rogerson, Marni Jacobs, Minhazur Sarker, Kim Boggess, Ashley N Battarbee, Jerrie Refuerzo, Noelia Zork, Gayle Olson, Celeste Durnwald, Kjersti Aagaard and 6 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in American journal of perinatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Daniella RogersonDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, San Diego, California, United States.ORCID 0009-0009-7043-9805
Marni JacobsDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, San Diego, California, United States.
Minhazur SarkerDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, San Diego, California, United States.
Kim BoggessDepartment of Obstetrics & Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States.
Ashley N BattarbeeDivision of Maternal-Fetal Medicine, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States.
Jerrie RefuerzoDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Health Houston McGovern Medical School, Houston, Texas, United States.
Noelia ZorkDivision of Maternal Fetal Medicine, Columbia University Irving Medical Center, New York, New York, United States.
Gayle OlsonDepartment of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas, United States.
Celeste DurnwaldDepartment of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States.
Kjersti AagaardDivision of Maternal Fetal Medicine, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, United States.
Kedra WallaceDepartment of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson, Mississippi, United States.
Christina ScifresDivision of Maternal Fetal Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States.ORCID 0000-0003-2992-7187
Todd RosenDivision of Maternal Fetal Medicine, Rutgers Health/Robert Wood Johnson Medical School, Brunswick, New Jersey, United States.
Sherri LongoDivision of Maternal Fetal Medicine, Ochsner Health, New Orleans, Louisiana, United States.
Gladys A RamosDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, San Diego, California, United States.
MOMPOD Study Consortium

Funding

TRAINING IN REPRODUCTIVE SCIENCEST32HD007203 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PAMELA L MELLON · 1988 to 2026
$4.8M
Medical optimization & management of pregnancies with overt type 2 diabetes (MOMPOD) - Admin Supplement 3: Effect of Overt Type 2 Diabetes and Metformin Treatment on Placental Transport ProteinsR01HD086139 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BERRY, DIANE C, BOGGESS, KIM A · 2016 to 2021
$4.5M
Eunice Kennedy Shriver National Institute of Child Health and Human Development HD86139National Institute of Child Health and Human Development HD86139NICHD NIH HHS R01 HD086139NICHD NIH HHS T32 HD007203NIH T32 HD007203-42
6 · The paper itself

Abstract

Objective: Pregestational diabetes is associated with low prevalence of breastfeeding due to low rates of intent, delayed lactogenesis, and early infant separation. It is hypothesized that the perceived need for formula supplementation due to neonatal hypoglycemia, coupled with maternal low early milk supply, is a barrier to breastfeeding initiation. Whether there is an association between neonatal hypoglycemia and breastfeeding is unknown. We evaluated associations between neonatal hypoglycemia and breastfeeding. Study Design: This is a secondary analysis of a randomized controlled trial of metformin versus placebo plus insulin in participants with type 2 diabetes. We included participants who delivered a liveborn neonate, endorsed intention to breastfeed, and had neonatal hypoglycemia data available. A breastfeeding questionnaire was administered at 30-day postpartum, and outcomes were compared between neonates with and without hypoglycemia. The primary outcome was prevalence of exclusive, partial, or no breastfeeding at 30-day postpartum. Secondary outcomes included time to breastfeeding cessation and contributing factors. Characteristics were compared with chi-square, Results: A total of 420 participants in the primary study (53%) completed an antepartum survey, including a question about intent to breastfeed. After exclusion criteria were applied, 370 (91%) of 405 possible participants reported intention to breastfeed. Among these 370 who met criteria and had intention to breastfeed, 265 (72%) responded to the 30-day postpartum questionnaire. Of these 265, 114 (43%) had neonatal hypoglycemia and 151 (57.0%) did not. Prevalence of not breastfeeding (35 vs. 37%), exclusive breastfeeding (18 vs. 13%), and partial breastfeeding (47 vs. 50%) did not differ between neonates with and without hypoglycemia ( Conclusion: This study found no impact of neonatal hypoglycemia on 30-day postpartum breastfeeding prevalence among participants with diabetes. Key Points: · Type 2 diabetes reduces the likelihood of breastfeeding, and the barriers are not fully known.. · Neonatal hypoglycemia is hypothesized to be one barrier to breastfeeding among this population.. · Neonatal hypoglycemia did not impact breastfeeding among diabetic gravidas 30-day postpartum.. · This remained true among neonates admitted to the neonatal intensive care unit.. · Further research examining barriers to breastfeeding among gravidas with diabetes is needed..

Indexed as

Breast FeedingDiabetes Mellitus, Type 2HypoglycemiaPregnancy in DiabeticsAdultFemaleHumansHypoglycemic AgentsInfant, NewbornInsulinMetforminPostpartum PeriodPregnancySurveys and QuestionnairesHypoglycemic AgentsInsulinMetformin

Identifiers

PMID41806854
PMCPMC13091607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.